Special Interview with Dr. Fenling Fan
On November 17, 2025, we invited Dr. Ling Lin from Zhongshan Hospital, Fudan University, Shanghai, China, who as a youth editorial board member of The Journal of Cardiovascular Aging (JCA) conducted an interview with Dr. Fenling Fan, a clinical doctor from The First Affiliated Hospital of Xi'an Jiaotong University, China. Dr. Fan discussed his team's long-term work in pulmonary vascular diseases, particularly pulmonary embolism and pulmonary arterial hypertension, and their efforts in building China's early specialized and multidisciplinary centers for pulmonary arterial hypertension. Her research integrates clinical cardiology, interventional techniques, and translational medicine to improve outcomes in these complex and high-risk conditions. Looking ahead, he emphasized the importance of multidisciplinary collaboration and continued translational research to advance diagnosis and treatment strategies in pulmonary vascular and cardiovascular diseases.
Watch the conversation between Dr. Fenling Fan and Dr. Ling Lin:
Interview Questions:
1. Could you please briefly introduce the research work of your research group?
2. You have been deeply involved in the field of interventional treatment for structural heart diseases for a long time. Could you share the most impressive challenge you have encountered in the process of integrating clinical practice with research?
3. You were involved in promoting the concept of "multidisciplinary diagnosis and treatment for pulmonary arterial hypertension". What do you think is the crucial role that multidisciplinary collaboration (MDT) plays in the management of cardiovascular diseases?
4. In the treatment of patients with structural heart diseases or pulmonary hypertension, what new challenges and opportunities do clinical translational research present?
About Dr. Fenling Fan and Dr. Ling Lin:
Interviewee: Dr. Fenling Fan, head of Pulmonary Hypertensio Unit, Chief Expert of Pulmonary Hypertension - Multidisciplinary Team Center, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi, China. Her research interests focus on pulmonary vascular disease, structural heart diseases, hypertension, coronary heart diseases, heart failure, myocardial diseases. She is principal investigator of 3 projects of National Natural Science Foundation of China, leading principal investigator of international clinic trial and 14 National Multicenter Research Project. She has published over 100 papers in internationally renowned journals
Interviewer: Dr. Lin Ling is a researcher at Zhongshan Hospital, Fudan University, Shanghai, China. She has a strong background in mass spectrometry, high-throughput subcellular protein localization, and other multi-omics technologies. Her research interests focus on organ-on-chip models for cardiovascular diseases, spatiotemporal-resolved single-cell metabolic analysis, and organelle interactions in cardiovascular pathophysiology.
Editor: Alex Wang
Language Editor: Catherine Yang
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of The Journal of Cardiovascular Aging
